Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 05 04:00PM ET
3.49
Dollar change
+0.06
Percentage change
1.63
%
Index- P/E- EPS (ttm)-0.54 Insider Own6.79% Shs Outstand3.00M Perf Week-2.35%
Market Cap10.46M Forward P/E- EPS next Y-2.40 Insider Trans12.29% Shs Float2.80M Perf Month-0.97%
Income5.55M PEG- EPS next Q-0.60 Inst Own54.98% Short Float1.42% Perf Quarter-1.53%
Sales16.02M P/S0.65 EPS this Y103.07% Inst Trans40.73% Short Ratio1.55 Perf Half Y-10.34%
Book/sh10.01 P/B0.35 EPS next Y-422.42% ROA20.40% Short Interest0.04M Perf Year-27.61%
Cash/sh9.68 P/C0.36 EPS next 5Y- ROE29.11% 52W Range3.00 - 8.98 Perf YTD-25.86%
Dividend Est.- P/FCF1.28 EPS past 5Y56.98% ROI18.46% 52W High-61.19% Beta-0.48
Dividend TTM- Quick Ratio8.97 Sales past 5Y-27.40% Gross Margin99.65% 52W Low16.20% ATR (14)0.21
Dividend Ex-Date- Current Ratio8.97 EPS Y/Y TTM101.84% Oper. Margin38.05% RSI (14)51.29 Volatility6.17% 5.74%
Employees12 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin34.64% Recom1.00 Target Price30.33
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q89.84% Payout- Rel Volume0.25 Prev Close3.43
Sales Surprise-100.00% EPS Surprise-6.12% Sales Q/Q- EarningsNov 08 BMO Avg Volume25.63K Price3.49
SMA201.74% SMA500.29% SMA200-18.56% Trades Volume6,373 Change1.63%
Nov-08-24 07:00AM
Oct-30-24 07:28AM
Oct-29-24 06:45AM
Sep-25-24 09:55AM
Aug-09-24 02:53PM
07:00AM Loading…
07:00AM
Aug-06-24 07:03AM
Jul-30-24 06:45AM
Jul-10-24 07:00AM
Jul-01-24 06:54AM
Jun-25-24 06:45AM
Jun-18-24 09:40AM
May-29-24 06:44PM
May-20-24 07:00AM
May-10-24 01:54PM
07:00AM Loading…
07:00AM
May-08-24 07:00AM
May-06-24 07:00AM
Apr-11-24 07:00AM
Apr-05-24 07:00AM
Mar-28-24 06:45AM
Mar-25-24 07:00AM
Mar-08-24 07:00AM
Feb-01-24 08:14AM
Jan-31-24 06:40PM
05:15PM
Nov-17-23 01:54PM
Nov-09-23 07:18AM
Nov-04-23 12:15PM
Oct-16-23 07:00AM
07:00AM Loading…
Oct-03-23 07:00AM
Sep-21-23 07:00AM
Sep-18-23 07:00AM
Sep-14-23 07:01AM
Sep-01-23 07:00AM
Aug-29-23 01:43PM
Aug-23-23 07:33PM
07:00AM
Aug-22-23 01:06PM
Aug-16-23 07:00AM
Aug-08-23 07:00AM
Aug-03-23 07:00AM
Aug-01-23 07:00AM
Jul-05-23 07:00AM
Jun-23-23 08:35AM
Jun-20-23 10:58AM
Jun-15-23 07:00AM
Jun-14-23 08:00AM
Jun-06-23 04:30PM
Jun-02-23 08:30AM
May-09-23 07:00AM
May-01-23 07:00AM
Apr-27-23 02:55PM
Apr-26-23 07:00AM
Apr-21-23 07:00AM
Apr-17-23 07:00AM
Mar-30-23 07:00AM
Mar-23-23 07:00AM
Mar-10-23 07:00AM
Feb-09-23 12:00PM
Feb-07-23 08:00AM
07:00AM
Feb-03-23 07:00AM
Jan-09-23 07:00AM
Jan-03-23 07:01AM
Dec-14-22 08:19AM
Nov-18-22 08:30AM
Nov-17-22 06:45AM
Nov-09-22 06:45AM
Oct-31-22 08:01AM
Oct-17-22 08:00AM
Oct-13-22 06:45AM
Sep-28-22 11:44AM
Sep-26-22 06:45AM
Sep-13-22 06:45AM
Aug-15-22 06:30AM
Aug-12-22 06:45AM
Jul-28-22 06:45AM
Jul-26-22 04:38PM
Jul-22-22 08:30AM
Jul-05-22 06:45AM
Jun-27-22 06:53AM
May-31-22 04:30PM
Apr-25-22 06:45AM
Apr-15-22 09:00AM
Mar-21-22 06:45AM
Mar-18-22 12:00PM
06:45AM
Feb-08-22 06:45AM
Feb-01-22 06:45AM
Jan-05-22 07:00AM
Dec-15-21 07:00AM
Dec-14-21 07:15AM
Nov-15-21 07:30AM
Kiora Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102. The company was founded in 1998 and is headquartered in Encinitas, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stengone Carmine N.DirectorSep 11 '24Buy3.681,2504,6001,250Sep 12 06:32 AM
Shapiro AronDirectorSep 10 '24Buy3.603,00010,8003,000Sep 11 07:02 AM
Walters-Hoffert LisaDirectorAug 19 '24Buy3.861,2504,8251,250Aug 20 01:00 PM
TYLE PRAVEENDirectorAug 19 '24Buy3.965,00019,8005,014Aug 19 03:45 PM
Tosca MelissaCFOAug 14 '24Buy3.212,0006,42013,599Aug 15 04:17 PM
Tosca MelissaEVP FinanceJun 14 '24Buy5.251005253,979Jun 14 04:47 PM
Daniels Eric JosephChief Development OfficerJun 14 '24Buy5.291,4317,57011,222Jun 14 03:40 PM
Parsons ErinDirectorJun 13 '24Buy4.885,26025,6695,260Jun 13 03:51 PM
Strem Brian M.President and CEOJun 13 '24Buy5.003,00014,99714,531Jun 13 03:49 PM